These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7586290)

  • 21. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET.
    Altehoefer C; vom Dahl J; Bares R; Stöcklin GL; Büll U
    J Nucl Med; 1995 Nov; 36(11):2056-9. PubMed ID: 7472598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
    Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
    J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myocardial viability evaluation by nuclear cardiology].
    Bunko H; Hisada K
    Kokyu To Junkan; 1990 Mar; 38(3):201-8. PubMed ID: 2330451
    [No Abstract]   [Full Text] [Related]  

  • 25. Features of positron emission tomography as a probe for myocardial chemistry.
    Schelbert HR
    Eur J Nucl Med; 1986; 12 Suppl():S2-10. PubMed ID: 3490372
    [No Abstract]   [Full Text] [Related]  

  • 26. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 27. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 29. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
    J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.
    Tamaki N; Ohtani H; Yamashita K; Magata Y; Yonekura Y; Nohara R; Kambara H; Kawai C; Hirata K; Ban T
    J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thallium-201 uptake in lung cancer.
    Chin BB; Zukerberg BW; Buchpiguel C; Alavi A
    J Nucl Med; 1995 Aug; 36(8):1514-9. PubMed ID: 7629600
    [No Abstract]   [Full Text] [Related]  

  • 32. [Accumulation of fluorodeoxyglucose in ischemic myocardium. I. Comparison with myocardial perfusion at rest and during exercise].
    Yonekura Y; Senda M; Koide H; Saji H; Yamamoto K; Nishizawa S; Torizuka K; Fudo T; Hashimoto T; Kambara H
    Kaku Igaku; 1986 Oct; 23(10):1361-7. PubMed ID: 3493371
    [No Abstract]   [Full Text] [Related]  

  • 33. Imaging metabolism and biochemistry--a new look at the heart.
    Schelbert HR; Phelps ME; Shine KI
    Am Heart J; 1983 Mar; 105(3):522-6. PubMed ID: 6600873
    [No Abstract]   [Full Text] [Related]  

  • 34. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium.
    Bergmann SR
    J Nucl Med; 1994 Apr; 35(4 Suppl):15S-22S. PubMed ID: 8151408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of reversible myocardial tissue injury (stunning) after thrombolytic therapy using radioisotope imaging techniques.
    Parodi O
    J Nucl Biol Med (1991); 1991; 35(2):63-5. PubMed ID: 1834191
    [No Abstract]   [Full Text] [Related]  

  • 36. Iodine-123-labeled glucose analogs: prospects for a single-photon-emitting analog of fluorine-18-labeled deoxyglucose.
    Gatley SJ
    Nucl Med Biol; 1995 Oct; 22(7):829-35. PubMed ID: 8547880
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
    Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
    J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography of the heart.
    Bergmann SR; Fox KA; Geltman EM; Sobel BE
    Prog Cardiovasc Dis; 1985; 28(3):165-94. PubMed ID: 3877316
    [No Abstract]   [Full Text] [Related]  

  • 40. The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction.
    Henrich MM; Vester E; von der Lohe E; Herzog H; Simon H; Kuikka JT; Feinendegen LE
    J Nucl Med; 1991 Jul; 32(7):1353-7. PubMed ID: 2066789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.